Aeterna Zentaris Inc. (Nasdaq: AEZS) announced that it is expanding its promotion of APIFINY®, the only cancer-specific, non-PSA blood test ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE